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Summary:
Expression of intron-containing messages has been shown to occur in a variety of diseases, including lactic acidosis, Cowden Syndrome and several cancers. However, it is unknown whether these intron-containing messages result in protein production in vivo.
Indeed, intron-containing RNAs are typically retained in the nucleus, targeted for degradation or translationaly repressed. Here, we show that during vascular lesion formation in rats, an alternative isoform of the helix-loop-helix transcription factor Id3 (Id3a), generated by intron retention, is abundantly expressed. We demonstrate that Id3 is expressed early in lesion formation, when the proliferative index of the neointima is highest, and that Id3 promotes SMC proliferation, S-phase entry and inhibits transcription of the cell cycle inhibitor p21 Cip1 . Using an Id3a-specific antibody developed by our lab, we show that Id3a protein is induced during vascular lesion formation and that Id3a expression peaks late, when the proliferative index is low or declining and extensive apoptosis is observed. Furthermore, Id3a fails to promote SMC growth and S-phase entry or to inhibit p21
Cip1 promoter transactivation. In contrast, Id3a stimulates SMC apoptosis and inhibits endogenous Id3 production. Adenoviral delivery of Id3a inhibited lesion formation in balloon-injured rat carotid arteries in vivo. These data describe a novel feedback loop whereby intron retention generates an Id3 isoform that acts to limit SMC growth during vascular lesion formation, providing the first evidence that regulated intron retention can modulate a pathologic process in vivo.
Introduction:
Modulation of vascular smooth muscle cell (SMC) growth has emerged as a promising strategy for treating vascular proliferative disorders such as restenosis, vein graft failure and transplant arteriopathy (1;2). During vascular lesion formation, normally quiescent SMC in the vessel wall re-enter the cell cycle, proliferate and secrete matrix (3) . In addition to growth and proliferation, SMC in developing lesions demonstrate altered morphology and apoptotic activity (4) . Apoptosis may function to limit SMC growth and lesion size in vivo and has been associated with changes in the stability of atherosclerotic plaques (5;6). Thus, understanding the mechanisms that regulate SMC growth and apoptosis is of key importance.
The Id class of helix-loop-helix (HLH) proteins have been linked to cell cycle control in a variety of cell types (7;8) . The Id family of proteins consists of four members, Id1-4, whose functions do not appear to be completely redundant (7;9;10). Id proteins act as dominant-negative transcription factors and appear to promote cellular proliferation by blocking bHLH-mediated transactivation of genes involved in cell cycle control, such as the cyclin-dependent kinase inhibitor p21 Cip1 (11;12 Western blotting: Lysates were collected in mPER lysis buffer (Pierce, Rockford, Illinois). Samples were electrophoresed with 4-20% SDS gradient gels (NuPAGE, Invitrogen) and transferred to PVDF membrane (Sigma). Western blotting was performed with antibodies to Id3 (0.5 µg/mL, C-20, Santa Cruz Biotechnologies), p21 (1.0 µg/mL, PharMingen), α-tubulin (0.5 µg/mL, Sigma) or Id3a (1.0 µg/mL), followed by a 1:2,000 dilution of horseradish-peroxidase linked secondary antibody (Santa Cruz Biotechnologies).
Rat balloon endothelial denudation and gene delivery:
The rat carotid endothelial denudation model was performed using male 350 g Sprague-Dawley rats (Harlan Laboratories, San Diego, California) as described elsewhere 16 . Briefly, left common carotid arteries were blunt-dissected at the bifurcation and internal and external cartoids were ligated. A 1cm tip PTCA dilation catheter (Boston Scientific) was inserted through the external carotid into the common carotid and endothelial denudation was performed by inflation of the balloon and 3 passages down the common carotid. For vessels treated with gene delivery, the common carotid artery was ligated approximately 1cm distal to the bifurcation and a polyethylene catheter, inserted through the external carotid, was used to deliver 100 µL of adenovirus (1x10 10 pfu). After a 20m incubation, vessels were flushed with PBS and blood flow was restored through the carotid artery. Analysis of vessel morphometry: 5 cross-sections from 6 (Ad-βgal) or 7 (Ad-Id3a)
balloon-injured in vivo fixed rat arteries were stained with hematoxin-and-eosin (Sigma).
Cross-sections were imaged using an Olympus BH 2-RFCA microscope with an on line CCD camera (Olympus DP-70). The circumference of the lumen, internal elastic lamina (IEL) and external elastic lamina (EEL) were measured and used to calculate neointima and medial area (Image-Pro Plus, Media Cybernetics, Carlsbad, California). Statistical analysis was performed using a Mann-Whitney U-test due to the small sample size. A P < 0.05 was considered statistically significant.
Results:
Id3a is generated by intron retention:
Alternative splicing of Id3 pre-mRNA results in messages encoding two distinct protein isoforms with different carboxyl-termini (Fig. 1a) . Id3 message is generated by the removal of both introns in the pre-mRNA. Id3a message is the result of inclusion of intron 1, a 115-bp sequence encoding a unique 29-amino acid C-terminus.
To examine the processing of Id3 pre-mRNA, we used three expression plasmid constructs for transient transfection of cultured SMC: A plasmid encoding full-length Id3 pre-mRNA, containing intron 1 (pAdLox Id3 FL), one encoding Id3 cDNA, lacking intron 1 (pAdLox Id3) and one encoding an Id3 construct that contains intron 1, but does not allow for removal of the intron (pAdLox Id3a) (Fig. 1b) . This non-spliceable construct contains two point mutations, 330G A and 409G A, disturbing both the 5' splice site and a pseudo-splice site within intron 1, and a deletion removing the 3' splice site (Fig.1b) inclusion of intron 1 and thus production of Id3a, providing evidence that intron retention is the mechanism determining which message, and therefore protein, is produced.
Id3 and Id3a protein are differentially expressed following balloon injury:
We have previously used in situ hybridization to show that Id3a message is induced following vascular injury (13 To determine the time course of Id3 and Id3a expression in vivo following balloon injury, we used the rat carotid injury model (17) and harvested vessel lysates at various time points following injury for Western blot analysis ( Fig.2a and b) . Id3 protein expression, present at low levels in uninjured control vessels, was increased by 3 days post-injury, peaked at 7 days and returned to baseline levels by 28 days. In contrast, Id3a
protein, not detected in uninjured arteries, was induced following injury, peaked at 14 days post-injury and remained high through 28 days.
To examine the expression pattern of Id3 and Id3a in response to injury, we balloon injured rat carotid arteries and fixed injured arteries 14 days later for immunohistochemistry. Id3 protein expression was observed in the media and in the developing neointima in injured vessels ( Fig.2c and d) . Id3a is abundantly expressed in the neointima of injured vessels, but was absent from the media (Fig.2e and f) .
To confirm that our Id3a antibody does not cross-react with Id3 protein, we transfected HEK cells with Id3 or Id3a expression constructs (pAdLox Id3 and pAdLox Id3a), and examined lysates by Western Blotting with our monoclonal Id3a antibody or a commercially available Id3 antibody (Fig 2g) . Our Id3a antibody reacted with ectopically expressed Id3a protein, but showed no immuno-reactivity with Id3.
Id3 enhances SMC proliferation:
To determine the time course of Id3-induced effects on SMC proliferation, we infected cells with an adenoviral construct encoding either Id3 cDNA (lacking intron 1, Ad-Id3)
or GFP (Ad-GFP) and assayed for cell number. Ad-Id3 infection resulted in a significant increase in cell number at 12 and 24 hours post-infection (P < 0.03), with the effect at 24 hours being marked (Fig. 3a) . In agreement with this, cultured SMC from Id3 -/-mice demonstrated significantly reduced proliferation in the presence of serum (Fig. 3b) . AdId3 infected SMC displayed increased S-phase entry, as determined by BrdU incorporation, 4 and 16 hours (P < 0.03) post-infection (Fig. 3c) . Consistent with this,
Id3
-/-SMC entered S-phase at a reduced rate (P < 0.003) when compared with wild-type controls (Fig. 3d) .
Recent data provides evidence that all functions of the Id proteins are not redundant (7;9;10). Id3 has been implicated in the regulation of p21 Cip1 protein expression , however unlike Id1, the effects of Id3 on p21 Cip1 promoter activity is unknown (11;18). In promoter-reporter experiments, transient transfection of SMC with pAdLox Id3 was capable of dramatically inhibiting endogenous promoter activation of the cell-cycle inhibitor p21 Cip1 ( Fig. 3e , P < 0.003). Further, Id3 -/-SMC displayed a significant increase in p21 Cip1 promoter activation (P < 0.0006) and p21 Cip1 protein levels relative to wild-type control SMC (Fig. 3f) .
The effects of Id3a on SMC growth and viability:
Previous studies have demonstrated that the E-protein E47 effectively activates p21
Cip1 transcription, resulting in inhibition of cellular growth (11) . Accordingly, we evaluated the effect of Id3 and Id3a on E-protein-mediated p21 Cip1 transcription in SMC. Cotransfection of SMC with pcDNA-E47 and pAdLox Id3, but not pAdLox Id3a reduces luciferase activity (P < 0.01) to levels comparable to baseline, demonstrating that Id3a lacks the ability of Id3 to block E47 mediated p21 Cip1 transactivation. These observations are not attributable to differences in Id3 and Id3a expression, since both pAdLox Id3 and pAdLox Id3a transfection results in similar protein levels, as detected by Western blot using an antibody to their common N-terminus (Fig. 4a, insert) . Consistent with these data, and in contrast to Ad-Id3, infection of SMC with an Id3a-expressing adenovirus, Ad-Id3a, did not result in a significant difference in S-phase entry (Fig. 4b) .
Advanced vascular lesions demonstrate extensive apoptosis, a low proliferative index and robust Id3a expression. Accordingly, we assayed the effects of Id3a on SMC proliferation and apoptosis. Results confirm that, relative to control plasmid, pAdLox Id3a expression inhibits SMC proliferation ( Fig. 4c , P < 0.01). This correlates with the ability of Ad-Id3a to promote apoptosis in SMC 48 hours following infection ( Fig. 4d , P < 0.003).
It is intriguing to postulate that Id3a acts as a negative feedback molecule to limit Id3-induced growth. We therefore examined the effect of Ad-Id3a on Id3 protein levels, and found that Ad-Id3a infection results in a dose-dependent decrease in endogenous Id3 levels in SMC (Fig. 4e) . Because Id3 acts as a transcription regulator, we hypothesized that Id3a inhibits Id3 expression at the level of transcription. When co-transfected with an Id3 luciferase promoter-reporter construct, pAdLox Id3a resulted in an approximately 50% reduction in luciferase activity relative to empty vector (P < 0.001), whereas pAdLox Id3 had no significant effect on Id3 transcription (Fig. 4f) . cancer-yet it remains unclear whether herstatin protein is produced in vivo (15;22;23) .
Overexpression of Id3a in injured vessels inhibits neointimal formation:
Protein expression from intron-containing message has been described in the literature for several protein isoforms, including periaxin and sodium channel subunits (24;25).
However, the in vivo consequences of these events are not clear.
During early stages of vascular lesion formation, expression of the fully spliced
Id3 protein is increased when the proliferative index of the neointima is high, suggesting that Id3 acts to promote SMC growth in response to vascular injury (26;27) . Consistent with this hypothesis, ectopic Id3 expression promoted SMC proliferation and S-phase entry, while Id3 -/-SMC displayed reduced proliferation and S-phase entry. It has been shown previously that other Id proteins promote cellular growth by negatively regulating transcription of cell-cycle inhibitors, such as p21 Cip1 (11;12) . Indeed, we show that Id3 inhibited endogenous and E47-driven p21 Cip1 transcription in SMC and that Id3 -/-SMC had markedly increased p21 Cip1 transcription and protein levels, providing a mechanism for Id3-induced SMC proliferation.
Retention of intron 1 in the Id3 message yields a distinct protein isoform, termed Id3a, which encodes an alternative C-terminus. Id3a protein expression is not observed in vivo in quiescent vessels, but is induced following vascular injury. Unlike Id3, peak
Id3a expression corresponds to time points late in lesion formation, when the proliferative index of the neointima is declining or low and extensive apoptosis is observed (27;28) . Thus, we hypothesize that Id3a functions as part of a negative feedback loop to limit pathologic SMC proliferation (Fig. 5d ). This is in agreement with our cell culture data indicating that Id3a expression causes a decrease in SMC proliferation and the onset of apoptosis, as well as inhibition of Id3 expression. The ability of Id3a to inhibit neointimal formation in vivo when expressed immediately following vascular injury further supports this hypothesis.
Our results provide the first evidence that regulated intron retention is a key step in controlling SMC growth and viability and vascular lesion formation. The mechanisms that regulate the splicing and translation of Id3a and other intron-containing messages may provide novel and important insights into the molecular mechanisms that regulate cellular growth in response to vascular injury and other proliferative disorders. 
